Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dunkelgrun

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Coronary Artery Disease|December 19, 2006
Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgeryPeter G Noordzij, Don Poldermans, Olaf Schouten, et al.
Obesity Surgery|May 10, 2020
Correction to: One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgeryNathan Poublon, Ibtissam Chidi, Martijn Bethlehem, et al.
Obesity Surgery|April 21, 2020
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgeryNathan Poublon, Ibtissam Chidi, Martijn Bethlehem, et al.
Coronary Artery Disease|March 27, 2009
Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patientsDustin Goei, Sanne E Hoeks, Eric Boersma, et al.
European Journal of Endocrinology|January 16, 2007
Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgeryPeter G Noordzij, Eric Boersma, Frodo Schreiner, et al.
Obesity Surgery|October 2, 2024
Long-term Outcome of the Dutch Common Channel Trial (DUCATI): Preservation of Superior Weight Loss Results Without Significant Malnutrition Side EffectsRalph P M Gadiot, L Ulas Biter, Pierre G Feskens, et al.
Annals of Surgery|May 29, 2009
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV)Martin Dunkelgrun, Eric Boersma, Olaf Schouten, et al.
Obesity Surgery|September 21, 2020
Does the Length of the Common Channel as Part of the Total Alimentary Tract Matter? One Year Results from the Multicenter Dutch Common Channel Trial (DUCATI) Comparing Standard Versus Distal Roux-en-Y Gastric Bypass with Similar Biliopancreatic Bowel Limb LengthsRalph P M Gadiot, M Leeman, L Ulas Biter, et al.
Obesity Surgery|September 3, 2021
Midterm Results from the Dutch Common Channel Trial (DUCATI): Superior Weight Loss Results of the Long Roux Limb Gastric Bypass in Comparison to the Standard Bypass at 3-Year Follow-UpRalph P M Gadiot, L Ulas Biter, Pierre G Feskens, et al.
BMC Obesity|July 29, 2015
Study protocol of the DUCATI-study: a randomized controlled trial investigating the optimal common channel length in laparoscopic gastric bypass for morbid obese patientsRalph P M Gadiot, Brechtje A Grotenhuis, L Ulas Biter, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Coronary Artery Disease|December 19, 2006
Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgeryPeter G Noordzij, Don Poldermans, Olaf Schouten, et al.
Obesity Surgery|May 10, 2020
Correction to: One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgeryNathan Poublon, Ibtissam Chidi, Martijn Bethlehem, et al.
Obesity Surgery|April 21, 2020
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgeryNathan Poublon, Ibtissam Chidi, Martijn Bethlehem, et al.
Coronary Artery Disease|March 27, 2009
Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patientsDustin Goei, Sanne E Hoeks, Eric Boersma, et al.
European Journal of Endocrinology|January 16, 2007
Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgeryPeter G Noordzij, Eric Boersma, Frodo Schreiner, et al.
Obesity Surgery|October 2, 2024
Long-term Outcome of the Dutch Common Channel Trial (DUCATI): Preservation of Superior Weight Loss Results Without Significant Malnutrition Side EffectsRalph P M Gadiot, L Ulas Biter, Pierre G Feskens, et al.
Annals of Surgery|May 29, 2009
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV)Martin Dunkelgrun, Eric Boersma, Olaf Schouten, et al.
Obesity Surgery|September 21, 2020
Does the Length of the Common Channel as Part of the Total Alimentary Tract Matter? One Year Results from the Multicenter Dutch Common Channel Trial (DUCATI) Comparing Standard Versus Distal Roux-en-Y Gastric Bypass with Similar Biliopancreatic Bowel Limb LengthsRalph P M Gadiot, M Leeman, L Ulas Biter, et al.
Obesity Surgery|September 3, 2021
Midterm Results from the Dutch Common Channel Trial (DUCATI): Superior Weight Loss Results of the Long Roux Limb Gastric Bypass in Comparison to the Standard Bypass at 3-Year Follow-UpRalph P M Gadiot, L Ulas Biter, Pierre G Feskens, et al.
BMC Obesity|July 29, 2015
Study protocol of the DUCATI-study: a randomized controlled trial investigating the optimal common channel length in laparoscopic gastric bypass for morbid obese patientsRalph P M Gadiot, Brechtje A Grotenhuis, L Ulas Biter, et al.
Pageof 4